GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » FCF Margin %

Square Pharmaceuticals (DHA:SQURPHARMA) FCF Margin % : 21.79% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Square Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2023 was BDT4,036 Mil. Square Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was BDT18,519 Mil. Therefore, Square Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 21.79%.

As of today, Square Pharmaceuticals's current FCF Yield % is 6.43%.

The historical rank and industry rank for Square Pharmaceuticals's FCF Margin % or its related term are showing as below:

DHA:SQURPHARMA' s FCF Margin % Range Over the Past 10 Years
Min: 9.12   Med: 14.16   Max: 23.49
Current: 17.92


During the past 13 years, the highest FCF Margin % of Square Pharmaceuticals was 23.49%. The lowest was 9.12%. And the median was 14.16%.

DHA:SQURPHARMA's FCF Margin % is ranked better than
88.4% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs DHA:SQURPHARMA: 17.92


Square Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Square Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals FCF Margin % Chart

Square Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.49 19.00 14.16 11.62 9.12

Square Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.21 11.70 -11.34 42.52 21.79

Competitive Comparison of Square Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Square Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Square Pharmaceuticals's FCF Margin % falls into.



Square Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Square Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=5721.366/62747.683
=9.12 %

Square Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4036.202/18518.951
=21.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Square Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines